Presence of peripheral arterial disease predicts loss of residual renal function in incident capd patients

Peritoneal Dialysis International

Volumn 32, Issue 1, 2012, Pages 67-72

  Tian, Shun li ^a   Tian, Xin kui ^b   Han, Qing feng ^b   Axelsson, Jonas ^c   Wang, Tao ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Ankle brachial index; Atherosclerosis; Cardiovascular disease; End stage renal disease; Inflammation; Nutrition

Indexed keywords

C REACTIVE PROTEIN; CREATININE; PHOSPHATE; UREA; URIC ACID;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONITIS; PHOSPHATE BLOOD LEVEL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL SYSTEM PARAMETERS; RESIDUAL RENAL FUNCTION; UNIVERSITY HOSPITAL; URIC ACID BLOOD LEVEL;

AGED; CHINA; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UREA;

EID: 84863011454     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00109     Document Type: Article

References (32)

1. Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18:590-7.
2. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 2009; 24:2502-10.
3. Marrón B, Remón C, Pérez-Fontán M, Quirós P, Ortíz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl 2008; (108):S42-51.
4. Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin JAm Soc Nephrol 2007; 2:1317-28.
5. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000; 20:429-38.
6. Ignace S, Fouque D, Arkouche W, Steghens JP, Guebre-Egziabher F. Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24:1685-9.
7. Fogo AB. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am JKidney Dis 2000; 35:179-88.
8. Liao CT, Shiao CC, Huang JW, Hung KY, Chuang HF, Chen YM, et al. Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients. Perit Dial Int 2008; 28(Suppl 3):S191-5.
9. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int 2001; 21:302-5.
10. Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009; 24:2909-14.
11. Coronel F, Perez-Flores I, Calvo N, Martinez-Villaescusa M, Cigarran S. Impact of cardiovascular events on residual renal function during the first year of peritoneal dialysis. Perit Dial Int 2007; 27:454-6.
12. Liu JH, Lin HH, Yang YF, Liu YL, Kuo HL, Wang IK, et al. Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int 2009; 29:64-71.
13. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. JAm Soc Nephrol 2002; 13:497-503.
14. O'Hare AM, Rodriguez RA, Bacchetti P. Low ankle-brachial index associated with rise in creatinine level over time: results from the Atherosclerosis Risk in Communities study. Arch Intern Med 2005; 165:1481-5.
15. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am JEpidemiol 1994; 140:526-34.
16. Shanley PF. The pathology of chronic renal ischemia. Semin Nephrol 1996; 16:21-32.
17. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-53.
18. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. JAm Soc Nephrol 2000; 11:556-64.
19. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 2006; 295:180-9.
20. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am JMed 1994; 96:10-14.
21. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114:688-99.
22. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): executive summary. A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. JAm Coll Cardiol 2006; 47:1239-312.
23. Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16:2240-5.
24. Breborowicz A, Pawlaczyk K, Polubinska A, Górna K, Wieslander A, Carlsson O, et al. Effect of peritoneal dialysis on renal morphology and function. Nephrol Dial Transplant 2006; 21:3539-44.
25. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am JKidney Dis 1999; 34:14-20.
26. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 2003; 23:276-83.
27. Koizumi T, Murakami K, Nakayama H, Kuwahara T, Ohnishi Y. Role of dietary phosphorus in the progression of renal failure. Biochem Biophys Res Commun 2002; 295:917-21.
28. Noordzij M, Voormolen NM, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. Nephrol Dial Transplant 2009; 24:1580-7.
29. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22:2909-16.
30. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003; 138:460-7.
31. Barsotti G, Giannoni A, Morelli E, Lazzeri M, Vlamis I, Baldi R, et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984; 21:54-9.
32. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am JKidney Dis 1998; 31:954-61.